Interleukin-37 expression is decreased in Behçet's disease and is associated with inflammation

Sugita, 2013, Role of IL-22- and TNF-α-producing Th22 cells in uveitis patients with Behcet's disease, J. Immunol., 190, 5799, 10.4049/jimmunol.1202677 Zhou, 2012, Cytokines and Behcet's disease, Autoimmun. Rev., 11, 699, 10.1016/j.autrev.2011.12.005 Hamzaoui, 2011, Expression of Th-17 and RORγt mRNA in Behçet's disease, Med. Sci. Monit., 17, CR227, 10.12659/MSM.881720 Hamzaoui, 2011, RORC and Foxp3 axis in cerebrospinal fluid of patients with neuro-Behçet's disease, J. Neuroimmunol., 233, 249, 10.1016/j.jneuroim.2011.01.012 Hamzaoui, 2002, Cytokine profile in Behçet's disease patients. Relationship with disease activity, Scand. J. Rheumatol., 31, 205, 10.1080/030097402320318387 Melikoglu, 2006, Characterization of the divergent wound healing responses occurring in the pathergy reaction and normal healthy volunteers, J. Immunol., 177, 6415, 10.4049/jimmunol.177.9.6415 Shimizu, 2015, Possible association of proinflammatory cytokines including IL1β and TNFα with enhanced Th17 cell differentiation in patients with Behcet's disease, Clin. Rheumatol. Manzanillo, 2015, Deciphering the crosstalk among IL-1 and IL-10 family cytokines in intestinal immunity, Trends Immunol., S1471 Busfield, 2000, Identification and gene organization of three novel members of the IL-1 family on human chromosome 2, Genomics, 66, 213, 10.1006/geno.2000.6184 Pan, 2001, IL-1H, an interleukin-1-related protein that binds IL-18 receptor/IL-1Rrp, Cytokine, 13, 1, 10.1006/cyto.2000.0799 Nold, 2010, IL-37 is a fundamental inhibitor of innate immunity, Nat. Immunol., 11, 1014, 10.1038/ni.1944 Liang, 2014, IL-37 inhibits the production of inflammatory cytokines in peripheral bloodmononuclear cells of patients with systemic lupus erythematosus, its correlation with disease activity, J. Transl. Med., 12, 69, 10.1186/1479-5876-12-69 Zhao, 2014, Plasma levels of IL-37 and correlation with TNF-α, IL-17A, and disease activity during DMARD treatment of rheumatoid arthritis, PLoS One, 9, e95346, 10.1371/journal.pone.0095346 Song, 2013, Glucocorticoid regulates interleukin-3 in systemic lupus erythematosus, J. Clin. Immunol., 33, 111, 10.1007/s10875-012-9791-z Luo, 2013, IL-37 suppresses contact hypersensitivity by inducing tolerogenic dendritic cells, Cytokine, 63, 283, 10.1016/j.cyto.2013.06.174 International Study Group for Behcet's Disease, 1990, International Study Group for Behcet's disease. Criteria for diagnosis of Behcet's disease, Lancet, 335, 1078 Touzot, 2015, IFN-α induces IL-10 production and tilt the balance between Th1 and Th17 in Behçet disease, Autoimmun. Rev., 14, 370, 10.1016/j.autrev.2014.12.009 Cavuş, 2014, Increased IL-23 receptor, TNF-α and IL-6 expression in individuals with the IL23R-IL12RB2 locus polymorphism, Immunol. Lett., 160, 96, 10.1016/j.imlet.2014.01.001 Ye, 2015, Decreased interleukin-37 expression in Vogt-Koyanagi-Harada disease and upregulation following immunosuppressive treatment, J. Interferon Cytokine Res., 35, 265, 10.1089/jir.2014.0042 Boraschi, 2011, IL-37, a new anti-inflammatory cytokine of the IL-1 family, Eur. Cytokine Netw., 22, 127, 10.1684/ecn.2011.0288 Ye, 2014, A possible role for interleukin 37 in the pathogenesis of Behcet's disease, Curr. Mol. Med., 14, 535, 10.2174/1566524014666140414210831 Hatemi, 2012, Behçet's syndrome: a critical digest of the recent literature, Clin. Exp. Rheumatol., 30, S80 Pay, 2007, Dendritic cell subsets and type I interferon system in Behçet's disease: does functional abnormality in plasmacytoid dendritic cells contribute to Th1 polarization?, Clin. Exp. Rheumatol., 25, S34 Wu W., Luo Y., Wang W, Yu G, Shen Y, Sun Z, et al. Interleukin-37 inhibits the activation of mouse dendritic cells induced by lipopolysaccharides]. Xi Bao Yu Fen ZiMian Yi XueZaZhi.(2015); 31(4):433-6. Moretti, 2014, IL-37 inhibits inflammasome activation and disease severity in murine aspergillosis, PLoS Pathog., 10, e1004462, 10.1371/journal.ppat.1004462 Hamzaoui, 2012, Immunological responses in patients with Behçet's disease: advances in understanding, Expert Rev. Ophtalmol., 7, 261, 10.1586/eop.12.30 Velhoen, 2006, TGFb in the context of an inflammatory cytokinemilieu supports de novo differentiation ofIL-17-producing T cells, Immunity, 24, 179, 10.1016/j.immuni.2006.01.001 Ye, 2015, IL-37 alleviates rheumatoid arthritis by suppressing IL-17 and IL-17-triggering cytokine production and limiting Th17 cell proliferation, J. Immunol., 194, 5110, 10.4049/jimmunol.1401810 Bufler, 2004, Interleukin-1 homologues IL-1F7b and IL-18 contain functional mRNA instability elements within the coding region responsive to lipopolysaccharide, Biochem. J., 381, 503, 10.1042/BJ20040217 Li, 2015, Extracellular forms of IL-37 inhibit innate inflammation in vitro and in vivo but require the IL-1 family decoy receptorIL-1R8, Proc. Natl. Acad. Sci. U. S. A., 2497, 10.1073/pnas.1424626112 Sakai, 2012, Interleukin-37 reduces liver inflammatory injury via effects on hepatocytes and non-parenchymal cells, J. Gastroenterol. Hepatol., 27, 1609, 10.1111/j.1440-1746.2012.07187.x Teng, 2014, IL-37 ameliorates the inflammatory process in psoriasis by suppressing proinflammatory cytokine production, J. Immunol., 192, 1815, 10.4049/jimmunol.1300047 van de Veerdonk, 2014, Protective host defenseagainstdisseminatedcandidiasisisimpaired in miceexpressing human interleukin-37, Front. Microbiol., 5, 762 Arida, 2014, Anti-cytokine biologic treatment beyond anti-TNF in Behçet's disease, Clin. Exp. Rheumatol., 32, S149 Calvo-Río, 2014, Anti-TNF-í therapy in patients with refractoryuveitis due to Beháet's disease: a 1-year follow-up study of 124 patients, Rheumatology (Oxford), 53, 2223, 10.1093/rheumatology/keu266 Addimanda, 2015, Tocilizumab for severerefractoryneuro-Behçet: three cases IL-6 blockade in neuro-Behçet, Semin. Arthritis Rheum., 44, 472, 10.1016/j.semarthrit.2014.08.004